LOGIN  |  REGISTER
Chimerix

Recent Insider Transactions - Pasithea Therapeutics (NASDAQ: KTTA)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ KTTA Pasithea Therapeutics
STEINMAN LAWRENCE / director
10/24/2025
Buy
$0.72
242,913
$174K
242,913
NASDAQ KTTA Pasithea Therapeutics
Schneiderman Daniel H / officer: Chief Financial Officer
10/24/2025
Buy
$0.72
317,266
$227K
317,266
NASDAQ KTTA Pasithea Therapeutics
Novak Alfred J / director
10/24/2025
Buy
$0.72
42,913
$31K
42,913
NASDAQ KTTA Pasithea Therapeutics
Marques Tiago / director, officer: Chief Executive Officer
10/24/2025
Buy
$0.72
493,341
$353K
493,341
NASDAQ KTTA Pasithea Therapeutics
Leahy Emer / director
10/24/2025
Buy
$0.72
42,913
$31K
42,913
NASDAQ KTTA Pasithea Therapeutics
Dumesnil Simon / director
10/24/2025
Buy
$0.72
42,913
$31K
42,913